SOLV | Solventum CorporationNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$84.75
+$3.42 (+4.21%)

Solventum Corporation (SOLV) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily and the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
between the two $84.75 vs 50 $88.00 / 200 $78.39
Projection
No cross projected
Test
No active test
Last cross
Golden cross 1 Jul 2026 ยท projected 27 bars out ยท tested 4 bars

Weekly

No weekly data

Cross history

6
crosses on record since 2025
3 golden3 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Jul 2026Golden moderatedaily27 bars out4 bar cross test
20 Mar 2026Death steepdaily25 bars outNot tested
25 Nov 2025Golden moderatedaily27 bars outNot tested
14 Oct 2025Death flatdaily10 bars out4 bar cross test
1 Jul 2025Golden moderatedaily26 bars out1 bar cross test

About SOLV

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$84M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.